Last updated: October 21, 2026
A red light therapy panel may feel warm during use. That warmth tells you little about how much useful light reaches the skin, and it does not establish whether a session is effective.
What is the temperature of phototherapy? There is no single temperature that applies to every device or treatment. In red and near-infrared photobiomodulation, heating is not the intended treatment mechanism, but both the device and the skin can warm up. The amount depends on optical output, exposure time, distance, ventilation, and the person using it.
The practical questions are how hot the equipment becomes, how skin temperature changes during exposure, and whether both remain within the conditions evaluated for that device.
What does "temperature" actually mean in phototherapy?
Three temperature concepts in phototherapy: device surface, skin, and tissue
Three measurements are easy to confuse:
- Device temperature: the temperature of the housing, LED board, power supply, and other components. These parts can operate at different temperatures.
- Skin-surface temperature: the temperature measured at the exposed skin, which depends on local conditions as well as light exposure.
- Temperature within tissue: heating below the surface, which cannot be established from a housing reading or a casual touch check.
Red and near-infrared photobiomodulation aims to influence biological processes through light absorption rather than deliberate tissue heating. The terminology and scope are discussed by Anders, Lanzafame, and Arany in their 2015 paper on photobiomodulation. Calling the approach nonthermal describes its intended mechanism; it does not mean that every exposure produces zero heat.
The broader word "phototherapy" also includes treatments with different purposes, such as blue-light treatment for neonatal jaundice. Their operating conditions should be assessed separately.
The numbers behind device temperature and therapeutic irradiance
Annotated red light therapy panel showing heat sink, LED array, fan, and irradiance at treatment distance
Irradiance, measured in milliwatts per square centimeter (mW/cm²), describes the optical power reaching a surface per unit area. Temperature, measured in degrees Celsius, describes its thermal condition. One cannot be substituted for the other.
LEDs generate heat internally, and some light absorbed by skin is converted to heat. Fans and heat sinks help remove heat from the equipment, but a cool housing does not prove that skin temperature will remain unchanged.
For a product comparison, request irradiance measurements at the intended operating distances and temperature measurements under stated test conditions. A single peak irradiance value cannot describe coverage, temperature rise, or suitability for a particular application.
REDDOT's hardware testing overview describes component temperature-rise checks alongside electrical and functional testing. These records answer different questions from an optical output report.
Irradiance vs. heat: what the numbers actually mean
Exposure time matters alongside irradiance. For constant irradiance:
Radiant exposure (J/cm²) = irradiance (mW/cm²) × time (seconds) ÷ 1,000.
For example, 30 mW/cm² applied for 100 seconds gives 3 J/cm² at the measurement plane. This is a calculation example, not a treatment recommendation. It does not predict tissue temperature or establish clinical benefit.
Optical safety also depends on wavelength and exposure conditions. IEC 62471:2006 provides exposure limits, measurement methods, and a classification framework for photobiological hazards from lamps and lamp systems, including LEDs. A useful report identifies the tested model, configuration, distance, and assessment conditions.
Why lower-power devices feel different: a real product example
A small local-use lamp and a full-body panel expose different areas and use different optical arrangements. Their advertised electrical wattages alone cannot explain how warm either will feel.
Likewise, a contact device or intranasal device requires an assessment suited to its contact conditions and intended anatomy. A result from a noncontact panel cannot simply be transferred to a device used against skin or near mucous membranes.
Near-infrared output around 850 nm is largely invisible. Neither visible brightness nor the absence of warmth is a reliable measure of exposure.
Skin-surface temperature during a phototherapy session: what clinical data and guidelines say
Practitioner positioning red light panel at measured distance from patient's back in clinic
There is no universal skin-temperature rise for red light therapy. Body site, starting temperature, pigmentation, circulation, irradiance, and session length can affect the result. A claim such as "skin temperature rises by only 1–2°C" needs evidence from the actual device and exposure conditions.
Published research has measured skin temperature and microcirculation together, including a randomized controlled study of responses to photobiomodulation. Such measurements help assess a specific protocol; they do not establish a temperature guarantee for all panels and users.
The ICNIRP guidelines on visible and infrared radiation address optical exposure hazards. They should not be reduced to one universal "safe skin temperature" or used as proof that an untested product is safe at any distance.
Neonatal phototherapy needs separate clinical monitoring. NICE guidance on jaundice calls for monitoring the baby's temperature and hydration during treatment. Equipment placement follows the particular system's instructions and clinical protocol; adult panel distances do not apply.
When users report feeling hot: separating sensation from hazard
Warmth can come from absorbed light, heat released by the equipment, or rising room temperature. Changes in circulation may contribute, but sensation alone cannot identify the cause.
Persistent or uncomfortable heat deserves attention. Stop the session if there is burning, pain, or skin irritation, and check the device instructions before using it again. Keep ventilation openings clear and use the specified distance and settings.
For product teams, a report of excessive heat should lead to a repeatable investigation: record the room temperature, operating mode, session duration, distance, and location of the hot area. Check airflow and component temperatures rather than relying on a touch test.
Mechanical changes also need review. A new reinforcement plate, revised enclosure, or relocated circuit board can change electrical clearances and airflow. Temperature and electrical-safety checks should reflect the final production design.
How certification connects to thermal safety in practice
Phototherapy panel documentation comparison: temperature testing, optical safety, and traceability
Different documents support different conclusions. A dielectric withstand test checks insulation under a specified electrical stress. It does not measure skin temperature, establish optical safety, or replace a temperature-rise test.
For medical electrical equipment, IEC 60601-1 addresses basic safety and essential performance. Applicable collateral and particular standards may also be needed. A report that names the standard should still identify its edition, the tested model, relevant clauses, and results.
A temperature-rise report should state the ambient baseline, supply conditions, operating mode, measurement locations, test duration, maximum readings, and applicable limits. Buyers should be able to connect each result to the delivered configuration.
ISO 13485:2016 concerns the manufacturer's quality management system. It supports controlled production and records, but the certificate is not a temperature test report for every product in the catalogue.
Similarly, an ETL Listed Mark relates to the standards and models covered by the listing. Verify that scope rather than assuming that the mark includes every optical and thermal assessment.
CE marking requires the applicable conformity assessment and supporting documentation. The European Commission's Low Voltage Directive guidance explains the manufacturer's responsibilities for products within its scope. The applicable legislation depends on the product and intended use; CE marking is not a single third-party test program.
FDA establishment registration and device listing are also distinct from product approval. FDA explicitly states that registration and listing do not denote approval, clearance, or authorization. They should not be presented as independent verification of thermal safety.
For an overview of equipment-level checks, see REDDOT's temperature-rise and electrical-safety testing methods.
High-power panels and skin temperature: what distance controls
Measured irradiance comparison at 6, 12, and 24 inches from a red light panel
Moving farther from a panel generally changes the irradiance reaching the skin and can reduce warmth. The size of that change needs measurement.
The familiar inverse-square rule describes a point-source approximation. At typical close operating distances, a large LED panel is an extended source with overlapping beams. Doubling the distance therefore does not reliably reduce irradiance to one-quarter. Lens angle, panel dimensions, and position within the light field all affect the result.
Distance is one control; intensity, exposure time, room conditions, and ventilation also matter. A preset name alone does not establish the delivered dose or a clinically validated use.
Cooling fans help manage internal heat, but fan count does not establish a maximum housing or skin temperature. A stated LED lifetime likewise needs its test conditions and failure criteria; it is not a guarantee that the complete device will operate for that duration.
Key Takeaways
Photobiomodulation is intended to act through light absorption rather than deliberate heating, yet equipment and skin can still warm during use. Evaluate irradiance, temperature rise, and safety documentation separately. Follow the instructions for the exact device, and request measurements when comparing products.
FAQ
How fast does phototherapy lower bilirubin?
The response varies with the infant's condition and the treatment delivered. NICE recommends checking serum bilirubin 4–6 hours after starting phototherapy. This is a monitoring interval, not a guaranteed time to resolution. Clinicians use the trend to judge response.
How many minutes is phototherapy?
There is no universal session length. Adult red and near-infrared devices should be used according to their validated instructions and any relevant clinical guidance. Neonatal jaundice treatment may continue for extended periods, with breaks determined by the care team; NICE distinguishes routine phototherapy from intensified treatment.
Is 250 high for jaundice?
If the unit is µmol/L, 250 is approximately 14.6 mg/dL. The number alone does not determine whether phototherapy is needed. The AAP guideline for infants born at 35 weeks or later uses age in hours, gestational age, and neurotoxicity risk factors to determine treatment thresholds. A clinician should interpret the result promptly, especially when jaundice appears in the first 24 hours.
How many hours of phototherapy for jaundice?
Treatment ends according to bilirubin results and clinical criteria rather than a fixed number of hours. Some infants require longer treatment or follow-up for rebound. The AAP guideline bases follow-up testing on the infant's risk and treatment history; one rebound-testing schedule does not apply to every baby.
References
- Anders JJ, Lanzafame RJ, Arany PR. Low-Level Light/Laser Therapy Versus Photobiomodulation Therapy. Photomedicine and Laser Surgery. 2015;33(4):183–184.
- Microcirculatory Response to Photobiomodulation—Why Some Respond and Others Do Not: A Randomized Controlled Study. 2020.
- ICNIRP. Guidelines on Limits of Exposure to Incoherent Visible and Infrared Radiation. Health Physics. 2013;105(1):74–96.
- IEC. IEC 62471:2006: Photobiological Safety of Lamps and Lamp Systems.
- IEC. IEC 60601-1:2005+A1:2012+A2:2020: General Requirements for Basic Safety and Essential Performance.
- ISO. ISO 13485:2016: Medical Devices—Quality Management Systems.
- Intertek. ETL Listed Mark.
- European Commission. Low Voltage Directive.
- FDA. Important Reminders about Registration and Listing.
- American Academy of Pediatrics. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3):e2022058859.
- NICE. Jaundice in Newborn Babies Under 28 Days: Recommendations, CG98.
- World Health Organization. Managing Newborn Problems: A Guide for Doctors, Nurses, and Midwives. 2003. Background reference; use current clinical guidance for treatment decisions.
- REDDOT LED. Hardware Testing.